Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Moolec Science ( (MLEC) ) has shared an announcement.
On June 16, 2025, Moolec Science SA announced significant changes in its leadership structure, including the resignation of several board members and the appointment of new directors. The company also appointed Alejandro Antalich as the new Chief Executive Officer, while José López Lecube was reappointed as Chief Financial Officer. These changes are part of Moolec’s strategic efforts to strengthen its governance and continue its commitment to delivering value to stakeholders.
The most recent analyst rating on (MLEC) stock is a Buy with a $3.00 price target. To see the full list of analyst forecasts on Moolec Science stock, see the MLEC Stock Forecast page.
Spark’s Take on MLEC Stock
According to Spark, TipRanks’ AI Analyst, MLEC is a Neutral.
The overall score reflects significant financial challenges due to high leverage, negative profitability, and cash flow issues. Mixed technical indicators and a negative P/E ratio further highlight uncertainties in the stock’s potential for growth.
To see Spark’s full report on MLEC stock, click here.
More about Moolec Science
Moolec Science SA operates within the biotechnology industry, focusing on the development of plant-based ingredients for food and feed applications. The company is known for its innovative approach to molecular farming, which involves using plants to produce animal proteins, aiming to provide sustainable and scalable alternatives to traditional animal agriculture.
Average Trading Volume: 7,402
Technical Sentiment Signal: Strong Sell
Current Market Cap: $28.49M
For a thorough assessment of MLEC stock, go to TipRanks’ Stock Analysis page.